Company news

Dong-A ST Co., Ltd. news in 2024

Dong-A ST Co., Ltd.'s news releases, calls and decks from 2024, newest first.

View company

Dong-A ST’s IMULDOSA™ (ustekinumab-srlf), a Biosimilar to STELARA®, receives approval from US FDA

October 14, 2024

Decks in 2024